Gene · 6548
Papers3,457
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,457
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients. | Cancer Med | 2023 | 37326348 | PubTator, text mining | PubMed |
| Biological fractionation of lithium isotopes by cellular Na+/H+ exchangers unravels fundamental transport mechanisms. | iScience | 2023 | 37324528 | PubTator, text mining | PubMed |
| Mutual impact of adipocytes and colorectal cancer cells growing in co-culture conditions. | Cell Commun Signal | 2023 | 37316878 | PubTator, text mining | PubMed |
| CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis. | Sci Rep | 2023 | 37316699 | PubTator, text mining | PubMed |
| Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review. | Int J Mol Sci | 2023 | 37298344 | PubTator, text mining | PubMed |
| Glioblastoma Metabolism: Insights and Therapeutic Strategies. | Int J Mol Sci | 2023 | 37298093 | PubTator, text mining | PubMed |
| The Role of the Cardiac Biomarkers in the Renal Cell Carcinoma Multidisciplinary Management. | Diagnostics (Basel) | 2023 | 37296764 | PubTator, text mining | PubMed |
| Effects of new hypoglycemic drugs on cardiac remodeling: a systematic review and network meta-analysis. | BMC Cardiovasc Disord | 2023 | 37296380 | PubTator, text mining | PubMed |
| Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas. | J Neurooncol | 2023 | 37294422 | PubTator, text mining | PubMed |
| Efficacy and safety evaluation of SGLT2i on blood pressure control in patients with type 2 diabetes and hypertension: a new meta-analysis. | Diabetol Metab Syndr | 2023 | 37280615 | PubTator, text mining | PubMed |
| Comparison of the effects of empagliflozin and sotagliflozin on a zebrafish model of diabetic heart failure with reduced ejection fraction. | Exp Mol Med | 2023 | 37258583 | PubTator, text mining | PubMed |
| ITGB1BP1, a Novel Transcriptional Target of CD44-Downstream Signaling Promoting Cancer Cell Invasion. | Breast Cancer (Dove Med Press) | 2023 | 37252376 | PubTator, text mining | PubMed |
| The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy. | Front Pharmacol | 2023 | 37251321 | PubTator, text mining | PubMed |
| Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1. | Sci Rep | 2023 | 37248416 | PubTator, text mining | PubMed |
| Delivery of Chemotherapy Agents and Nucleic Acids with pH-Dependent Nanoparticles. | Pharmaceutics | 2023 | 37242725 | PubTator, text mining | PubMed |
| SGLT-2 Inhibitors and the Inflammasome: What's Next in the 21st Century? | Nutrients | 2023 | 37242177 | PubTator, text mining | PubMed |
| Calcium Homeostasis, Transporters, and Blockers in Health and Diseases of the Cardiovascular System. | Int J Mol Sci | 2023 | 37240147 | PubTator, text mining | PubMed |
| SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases. | Int J Mol Sci | 2023 | 37240080 | PubTator, text mining | PubMed |
| Roles of Specialized Chromatin and DNA Structures at Subtelomeres in Schizosaccharomyces pombe. | Biomolecules | 2023 | 37238680 | PubTator, text mining | PubMed |
| ERS International Congress 2022: highlights from the Respiratory Intensive Care Assembly. | ERJ Open Res | 2023 | 37228293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6548/papers?page=13